1. Home
  2. PROF vs PCK Comparison

PROF vs PCK Comparison

Compare PROF & PCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • PCK
  • Stock Information
  • Founded
  • PROF N/A
  • PCK 2002
  • Country
  • PROF Canada
  • PCK United States
  • Employees
  • PROF N/A
  • PCK N/A
  • Industry
  • PROF Medical/Dental Instruments
  • PCK Trusts Except Educational Religious and Charitable
  • Sector
  • PROF Health Care
  • PCK Finance
  • Exchange
  • PROF Nasdaq
  • PCK Nasdaq
  • Market Cap
  • PROF 201.2M
  • PCK 181.9M
  • IPO Year
  • PROF N/A
  • PCK N/A
  • Fundamental
  • Price
  • PROF $5.85
  • PCK $5.76
  • Analyst Decision
  • PROF Strong Buy
  • PCK
  • Analyst Count
  • PROF 1
  • PCK 0
  • Target Price
  • PROF $12.00
  • PCK N/A
  • AVG Volume (30 Days)
  • PROF 65.7K
  • PCK 79.7K
  • Earning Date
  • PROF 03-06-2025
  • PCK 01-01-0001
  • Dividend Yield
  • PROF N/A
  • PCK 4.58%
  • EPS Growth
  • PROF N/A
  • PCK N/A
  • EPS
  • PROF N/A
  • PCK N/A
  • Revenue
  • PROF $10,680,000.00
  • PCK N/A
  • Revenue This Year
  • PROF $165.23
  • PCK N/A
  • Revenue Next Year
  • PROF $96.94
  • PCK N/A
  • P/E Ratio
  • PROF N/A
  • PCK N/A
  • Revenue Growth
  • PROF 48.35
  • PCK N/A
  • 52 Week Low
  • PROF $4.75
  • PCK $4.85
  • 52 Week High
  • PROF $11.42
  • PCK $6.33
  • Technical
  • Relative Strength Index (RSI)
  • PROF 29.08
  • PCK 48.85
  • Support Level
  • PROF $4.75
  • PCK $5.68
  • Resistance Level
  • PROF $7.15
  • PCK $5.83
  • Average True Range (ATR)
  • PROF 0.47
  • PCK 0.07
  • MACD
  • PROF -0.12
  • PCK -0.01
  • Stochastic Oscillator
  • PROF 43.14
  • PCK 66.67

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About PCK Pimco California Municipal Income Fund II of Beneficial Interest

PIMCO CA Muni Income Fund II is a closed-ended investment company. Its investment objective is to seek to provide current income exempt from federal and California income tax. The company portfolio of investment comprises of different sector investments such as healthcare, education, property, and others.

Share on Social Networks: